Xilio Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
17.00
|
|
Average Rating
|
4.60
|
|
# Strong Buys
|
3
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-1.17
|
0.00
|
1.17
|
100.00%
|
|
2022-12-31
|
-0.80
|
0.00
|
0.80
|
100.00%
|
|
2022-09-30
|
-0.88
|
-0.72
|
0.16
|
18.18%
|
|
2022-06-30
|
-0.78
|
-0.90
|
-0.12
|
-15.38%
|
|
2022-03-31
|
-0.93
|
-0.78
|
0.15
|
16.13%
|
|
2021-12-31
|
-1.17
|
-0.98
|
0.19
|
16.24%
|
|
2021-09-30
|
-1.60
|
-21.27
|
-19.67
|
-1229.38%
|
|
2021-06-30
|
0.00
|
-2.28
|
-2.28
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.40
|
|
2021-12-31
|
-25.16
|
|
2020-12-31
|
-107.37
|
|
2019-12-31
|
-19.83
|